Revealed: maker of Wegovy ‘skinny jab’ is funding NHS weight-loss services
The Guardian - Pharmaceutical Industry
APRIL 1, 2023
Critics fear conflict of interest as Novo Nordisk helps medics ‘reduce unnecessary barriers’ to treatment for obesity The pharmaceutical company that makes Wegovy slimming jabs is funding the expansion of weight-loss services across England as it seeks to boost sales of its obesity drugs, the Observer can reveal. Novo Nordisk is paying the salaries of staff on NHS obesity teams and financing the launch and redesign of services, including giving £206,000 to a health partnership to transform its t
Let's personalize your content